Investor Presentaiton

Innovation and Globalization are Our Key Strategies Innovation Discover potentially global first-in-class assets + Build on robust pipeline Focus on unmet patients' needs ● Global leading R&D capabilities and cutting-edge technologies Innovent Globalization Develop and market Innovent products globally Innovent A premier global biopharmaceutical company Collaboration with leading global biopharmaceutical companies Expand Innovent's in-house R&D and commercial arms globally ● Expand manufacturing capacity globally By 2030, more commercialized products, including first-in-class products launched globally Confidential Copyright©2021 Innovent Biologics 38 88

View entire presentation